Potassium-Sparing Diuretics

Potassium-sparing diuretics are a class of medications that promote sodium and water excretion in the distal nephron and collecting duct while preserving systemic potassium levels They function primarily by directly inhibiting epithelial sodium channels (such as amiloride and triamterene) or by competitively antagonizing mineralocorticoid receptors to block aldosterone-mediated signaling (such as spironolactone and eplerenone) Clinically, these agents are widely utilized to manage hypertension, ...

Potassium-sparing diuretics are a class of medications that promote sodium and water excretion in the distal nephron and collecting duct while preserving systemic potassium levels They function primarily by directly inhibiting epithelial sodium channels (such as amiloride and triamterene) or by competitively antagonizing mineralocorticoid receptors to block aldosterone-mediated signaling (such as spironolactone and eplerenone) Aldosterone receptor antagonists in this class also serve a key thera...

Potassium-sparing diuretics are a class of medications that promote sodium and water excretion in the distal nephron and collecting duct while preserving systemic potassium levels They function primarily by directly inhibiting epithelial sodium channels (such as amiloride and triamterene) or by competitively antagonizing mineralocorticoid receptors to block aldosterone-mediated signaling (such as spironolactone and eplerenone) Clinically, these agents are widely utilized to manage hypertension, ...

Clinically, these agents are widely utilized to manage hypertension, heart failure, and edematous conditions associated with hepatic cirrhosis or nephrotic syndrome, frequently in combination with thiazide or loop diuretics to prevent treatment-induced hypokalemia

Clinically, these agents are widely utilized to manage hypertension, heart failure, and edematous conditions associated with hepatic cirrhosis or nephrotic syndrome, frequently in combination with thiazide or loop diuretics to prevent treatment-induced hypokalemia

Aldosterone receptor antagonists in this class also serve a key therapeutic role in managing primary aldosteronism and reducing cardiovascular mortality in heart failure